Merck Kgaa (MRK.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -84,000 | -47,000 | -109,000 | -221,000 | -73,000 |
| Other Working Capital | -395,000 | -408,000 | -266,000 | -1,324,000 | -612,000 |
| Other Operating Activity | 3,956,000 | 3,311,000 | 2,594,000 | 4,241,000 | 3,203,000 |
| Operating Cash Flow | $3,477,000 | $2,856,000 | $2,219,000 | $2,696,000 | $2,518,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,378,000 | -782,000 | -879,000 | -875,000 | -695,000 |
| Net Acquisitions | 36,000 | -5,130,000 | 3,129,000 | 150,000 | 213,000 |
| Purchase Of Investment | -778,000 | -196,000 | -75,000 | -219,000 | -347,000 |
| Sale Of Investment | 841,000 | 140,000 | 55,000 | 185,000 | 457,000 |
| Purchase Sale Intangibles | -62,000 | -185,000 | -39,000 | -388,000 | -130,000 |
| Other Investing Activity | 89,000 | 23,000 | 67,000 | 4,000 | 1,000 |
| Investing Cash Flow | $-1,340,000 | $-6,153,000 | $2,191,000 | $-1,147,000 | $-503,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -605,000 | 411,000 | N/A | N/A | N/A |
| Debt Issued | 2,876,000 | 3,888,000 | 407,000 | 496,000 | 1,117,000 |
| Debt Repayment | -3,106,000 | -1,708,000 | -642,000 | -1,246,000 | -1,001,000 |
| Dividend Paid | -168,000 | -162,000 | -755,000 | -621,000 | -597,000 |
| Other Financing Activity | -519,000 | -527,000 | -1,835,000 | -499,000 | -1,427,000 |
| Financing Cash Flow | $-1,522,000 | $1,902,000 | $-2,825,000 | $-1,870,000 | $-1,908,000 |
| Exchange Rate Effect | -40,000 | 5,000 | -5,000 | -30,000 | 8,000 |
| Beginning Cash Position | 781,000 | 2,170,000 | 589,000 | 939,000 | 832,000 |
| End Cash Position | 1,355,000 | 781,000 | 2,170,000 | 589,000 | 939,000 |
| Net Cash Flow | $615,000 | $-1,395,000 | $1,585,000 | $-321,000 | $107,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,477,000 | 2,856,000 | 2,219,000 | 2,696,000 | 2,518,000 |
| Capital Expenditure | -1,563,000 | -1,021,000 | -1,016,000 | -1,311,000 | -848,000 |
| Free Cash Flow | 1,914,000 | 1,835,000 | 1,203,000 | 1,385,000 | 1,670,000 |